Marte Bjørk, MD, PhD; Bettina Riedel, MD, PhD; Olav Spigset, MD, PhD; et al.
free access
has audio
JAMA Neurol. 2018;75(2):160-168. doi:10.1001/jamaneurol.2017.3897
This population-based cohort and Norwegian biobank study examines the association of folic acid supplements and maternal folate concentration in pregnancy with the frequency and degree of autistic traits in children exposed to antiepileptic drugs in utero.
-
Podcast:
Maternal Folic Acid Supplementation and Risk of Autistic Traits Following Exposure to Antiepileptic Drugs
James Gratwicke, MD, PhD; Ludvic Zrinzo, MD, PhD; Joshua Kahan, MD, PhD; et al.
free access
JAMA Neurol. 2018;75(2):169-178. doi:10.1001/jamaneurol.2017.3762
This randomized clinical trial evaluates the safety and potential symptomatic effects of deep brain stimulation of the nucleus basalis of Meynert in patients with Parkinson disease dementia.
Yong-Won Shin, MD; Kyung-Il Park, MD, PhD; Jangsup Moon, MD, PhD; et al.
free access
JAMA Neurol. 2018;75(2):179-186. doi:10.1001/jamaneurol.2017.3431
This study evaluates the relationship between bone mineral density and intracranial aneurysm.
Vladimir Skljarevski, MD; Tina M. Oakes, PhD; Qi Zhang, PhD; et al.
open access
JAMA Neurol. 2018;75(2):187-193. doi:10.1001/jamaneurol.2017.3859
This randomized clinical trial evaluates the effect of 5, 50, 120, and 300 mg galcanezumab vs placebo as prophylaxis for patients with migraine.
Nuria Lacuey, MD; Johnson P. Hampson, MSBME; Wanchat Theeranaew, PhD; et al.
free access
has multimedia
JAMA Neurol. 2018;75(2):194-202. doi:10.1001/jamaneurol.2017.3344
This case series identifies cortical control sites for human blood pressure regulation in humans.
-
Video:
Stimulation Session in Patient 7 Showing Hypotensive Responses Induced by Brodmann Area 25 Stimulation
-
Video:
Stimulation Session in Patient 12 Showing Hypotensive Responses Induced by Brodmann Area 25 Stimulation
Takao Hoshino, MD; Leila Sissani, BS; Julien Labreuche, BS; et al.
free access
JAMA Neurol. 2018;75(2):203-211. doi:10.1001/jamaneurol.2017.3960
This study explores the frequency of intracranial atherosclerotic disease in patients who have had a stroke and whether it coexists with systemic atherosclerotic lesions and other stroke etiologies.
Jonathan Graff-Radford, MD; Mekala R. Raman, PhD; Alejandro A. Rabinstein, MD; et al.
free access
JAMA Neurol. 2018;75(2):212-218. doi:10.1001/jamaneurol.2017.3392
This population-based study evaluates the association between blood pressure declines and microinfarcts found on autopsy in participants in the Mayo Clinic Study on Aging.
Margaret Schenkman, PhD, PT; Charity G. Moore, PhD; Wendy M. Kohrt, PhD; et al.
free access
JAMA Neurol. 2018;75(2):219-226. doi:10.1001/jamaneurol.2017.3517
This phase 2 randomized clinical trial examines the feasibility and safety of high-intensity treadmill exercise in patients with de novo Parkinson disease who are not taking medication and whether the effect on the motor system warrants a phase 3 trial.
Joseph R. Winer, MA; Anne Maass, PhD; Peter Pressman, MD; et al.
free access
JAMA Neurol. 2018;75(2):227-235. doi:10.1001/jamaneurol.2017.3713
This case-control study evaluates the associations between 尾-amyloid, tau pathology, and cognition by comparing cognitively normal and mildly cognitively impaired patients with Parkinson disease with healthy control participants.
Anne Bertrand, MD, PhD; Junhao Wen, MS; Daisy Rinaldi, PhD; et al.
free access
JAMA Neurol. 2018;75(2):236-245. doi:10.1001/jamaneurol.2017.4266
This multicenter cross-sectional study assesses the occurrence of cognitive, structural, and microstructural changes in presymptomatic carriers of C9orf72 mutation.